S149 Body Mass Index Changes After Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
Kanika Sehgal(Yale New Haven Hospital), Sahil Khanna(Mayo Clinic), Darrell S. Pardi(Mayo Clinic), Eric Battaglioli(Mayo Clinic in Arizona), Ross Dierkhising(Mayo Clinic), Purna Kashyap(Mayo Clinic), George Saffouri(Mayo Clinic in Arizona), Janice Cho(Mayo Clinic in Arizona)
Cited by 0
Related Papers
Gut microbes promote colonic serotonin production through an effect of short‐chain fatty acids on enterochromaffin cells
|The FASEB Journal|2014|1.3k
Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens
|Nature|2013|1.1k
US Immigration Westernizes the Human Gut Microbiome
|Cell|2018|850
Discovery and Characterization of Gut Microbiota Decarboxylases that Can Produce the Neurotransmitter Tryptamine
|Cell Host & Microbe|2014|765
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook
|Gastroenterology|2015|569